These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 35360442)

  • 1. Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease.
    Kumar A; Al-Hassi HO; Steed H; Phipps O; Brookes MJ
    Can J Gastroenterol Hepatol; 2022; 2022():8416578. PubMed ID: 35360442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn's disease.
    Han B; Tang D; Lv X; Fan J; Li S; Zhu H; Zhang J; Xu S; Xu X; Huang Z; Huang Z; Lin G; Zhan L; Lv X
    Gut Microbes; 2024; 16(1):2310894. PubMed ID: 38312103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's Disease-Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism.
    Briggs K; Tomar V; Ollberding N; Haberman Y; Bourgonje AR; Hu S; Chaaban L; Sunuwar L; Weersma RK; Denson LA; Melia JMP
    Inflamm Bowel Dis; 2024 Aug; 30(8):1379-1388. PubMed ID: 38289995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microbiome landscape in pediatric Crohn's disease and therapeutic implications.
    Fetter K; Weigel M; Ott B; Fritzenwanker M; Stricker S; de Laffolie J; Hain T
    Gut Microbes; 2023 Dec; 15(2):2247019. PubMed ID: 37614093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma bile acids in association with Crohn's disease.
    Kiasat A; Prast-Nielsen S; Rautiainen S; Engstrand L; Andersson F; Lindberg J; Schuppe-Koistinen I; Löf Granström A; Gustafsson UO
    Scand J Gastroenterol; 2024 Jun; 59(6):674-682. PubMed ID: 38505982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiotic gut microbiome: A key element of Crohn's disease.
    Øyri SF; Műzes G; Sipos F
    Comp Immunol Microbiol Infect Dis; 2015 Dec; 43():36-49. PubMed ID: 26616659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?
    Pavlidis P; Powell N; Vincent RP; Ehrlich D; Bjarnason I; Hayee B
    Aliment Pharmacol Ther; 2015 Oct; 42(7):802-17. PubMed ID: 26223936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts.
    Lewis JD; Daniel SG; Li H; Hao F; Patterson AD; Hecht AL; Brensinger CM; Wu GD; Bittinger K; ;
    Cell Mol Gastroenterol Hepatol; 2024; 18(3):101357. PubMed ID: 38750900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
    Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
    FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Acid Signaling in Inflammatory Bowel Disease.
    Bromke MA; Krzystek-Korpacka M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease.
    Connors J; Dunn KA; Allott J; Bandsma R; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
    ISME J; 2020 Mar; 14(3):702-713. PubMed ID: 31796936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches.
    Núñez-Sánchez MA; Melgar S; O'Donoghue K; Martínez-Sánchez MA; Fernández-Ruiz VE; Ferrer-Gómez M; Ruiz-Alcaraz AJ; Ramos-Molina B
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabonomics and the Gut Microbiome Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease.
    Ding NS; McDonald JAK; Perdones-Montero A; Rees DN; Adegbola SO; Misra R; Hendy P; Penez L; Marchesi JR; Holmes E; Sarafian MH; Hart AL
    J Crohns Colitis; 2020 Sep; 14(8):1090-1102. PubMed ID: 32119090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.
    Wang S; Martins R; Sullivan MC; Friedman ES; Misic AM; El-Fahmawi A; De Martinis ECP; O'Brien K; Chen Y; Bradley C; Zhang G; Berry ASF; Hunter CA; Baldassano RN; Rondeau MP; Beiting DP
    Microbiome; 2019 Aug; 7(1):126. PubMed ID: 31472697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
    Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
    Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitional and temporal changes in the mucosal and submucosal intestinal microbiota in advanced Crohn's disease of the terminal ileum.
    Chiodini RJ; Dowd SE; Barron JN; Galandiuk S; Davis B; Glassing A
    J Med Microbiol; 2018 Apr; 67(4):549-559. PubMed ID: 29458679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor.
    Gadaleta RM; Garcia-Irigoyen O; Cariello M; Scialpi N; Peres C; Vetrano S; Fiorino G; Danese S; Ko B; Luo J; Porru E; Roda A; Sabbà C; Moschetta A
    EBioMedicine; 2020 Apr; 54():102719. PubMed ID: 32259714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.
    McIlroy J; Ianiro G; Mukhopadhya I; Hansen R; Hold GL
    Aliment Pharmacol Ther; 2018 Jan; 47(1):26-42. PubMed ID: 29034981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
    Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
    Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.